Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.

Peckham E, Brabyn S, Cook L, Tew G, Gilbody S.

BMC Psychiatry. 2017 Jul 14;17(1):252. doi: 10.1186/s12888-017-1419-7.

2.

Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations.

Cather C, Pachas GN, Cieslak KM, Evins AE.

CNS Drugs. 2017 Jun;31(6):471-481. doi: 10.1007/s40263-017-0438-8. Review.

PMID:
28550660
3.

Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder.

Hirasawa-Fujita M, Bly MJ, Ellingrod VL, Dalack GW, Domino EF.

Clin Schizophr Relat Psychoses. Spring 2017;11(1):39-48. doi: 10.3371/1935-1232-11.1.39.

4.

The effects of nicotine in the neonatal quinpirole rodent model of psychosis: Neural plasticity mechanisms and nicotinic receptor changes.

Peterson DJ, Gill WD, Dose JM, Hoover DB, Pauly JR, Cummins ED, Burgess KC, Brown RW.

Behav Brain Res. 2017 May 15;325(Pt A):17-24. doi: 10.1016/j.bbr.2017.02.029. Epub 2017 Feb 21.

PMID:
28235586
5.

Smoking Cessation Intervention for Severe Mental Ill Health Trial (SCIMITAR+): study protocol for a randomised controlled trial.

Peckham E, Arundel C, Bailey D, Brownings S, Fairhurst C, Heron P, Li J, Parrott S, Gilbody S.

Trials. 2017 Jan 26;18(1):44. doi: 10.1186/s13063-017-1789-7.

6.

Cognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial Perspective.

Besson M, Forget B.

Front Psychiatry. 2016 Sep 21;7:160. eCollection 2016. Review.

7.

Smoking and Serum Lipid Profiles in Schizophrenia.

An HM, Tan YL, Tan SP, Shi J, Wang ZR, Yang FD, Huang XF, Soars JC, Kosten TR, Zhang XY.

Neurosci Bull. 2016 Aug;32(4):383-8. doi: 10.1007/s12264-016-0022-0. Epub 2016 Mar 28.

8.

Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.

Roberts E, Eden Evins A, McNeill A, Robson D.

Addiction. 2016 Apr;111(4):599-612. doi: 10.1111/add.13236. Epub 2016 Jan 19. Review.

9.

Cigarette Cravings, Impulsivity, and the Brain.

Potvin S, Tikàsz A, Dinh-Williams LL, Bourque J, Mendrek A.

Front Psychiatry. 2015 Sep 8;6:125. doi: 10.3389/fpsyt.2015.00125. eCollection 2015. Review.

10.

Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices.

Evins AE, Cather C, Laffer A.

Harv Rev Psychiatry. 2015 Mar-Apr;23(2):90-8. doi: 10.1097/HRP.0000000000000063. Review.

11.

Nicotine effects in adolescence and adulthood on cognition and α₄β₂-nicotinic receptors in the neonatal ventral hippocampal lesion rat model of schizophrenia.

Berg SA, Sentir AM, Bell RL, Engleman EA, Chambers RA.

Psychopharmacology (Berl). 2015 May;232(10):1681-92. doi: 10.1007/s00213-014-3800-2. Epub 2014 Nov 13.

12.

Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation.

Donny EC, Hatsukami DK, Benowitz NL, Sved AF, Tidey JW, Cassidy RN.

Prev Med. 2014 Nov;68:17-22. doi: 10.1016/j.ypmed.2014.06.020. Epub 2014 Jun 23. Review.

13.

Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.

Brunzell DH, McIntosh JM, Papke RL.

Ann N Y Acad Sci. 2014 Oct;1327:27-45. doi: 10.1111/nyas.12421. Epub 2014 Apr 14. Review.

14.

Smoking cessation and reduction in schizophrenia (SCARIS) with e-cigarette: study protocol for a randomized control trial.

Caponnetto P, Polosa R, Auditore R, Minutolo G, Signorelli M, Maglia M, Alamo A, Palermo F, Aguglia E.

Trials. 2014 Mar 22;15:88. doi: 10.1186/1745-6215-15-88.

15.

Smoking behaviour and mental health disorders--mutual influences and implications for therapy.

Minichino A, Bersani FS, Calò WK, Spagnoli F, Francesconi M, Vicinanza R, Delle Chiaie R, Biondi M.

Int J Environ Res Public Health. 2013 Oct 10;10(10):4790-811. doi: 10.3390/ijerph10104790. Review.

16.

Effects of smoking abstinence on cigarette craving, nicotine withdrawal, and nicotine reinforcement in smokers with and without schizophrenia.

Tidey JW, Colby SM, Xavier EM.

Nicotine Tob Res. 2014 Mar;16(3):326-34. doi: 10.1093/ntr/ntt152. Epub 2013 Oct 10.

17.

Cigarette Smoking and Health Characteristics in Individuals With Serious Mental Illness Enrolled in a Behavioral Weight Loss Trial.

Dickerson FB, Yu A, Dalcin A, Jerome GJ, Gennusa JV 3rd, Charleston J, Crum RM, Campbell L, Oefinger M, Appel LJ, Daumit GL.

J Dual Diagn. 2013 Jan 1;9(1):39-46.

18.

Investigation of cigarette smoking among male schizophrenia patients.

Jiang J, See YM, Subramaniam M, Lee J.

PLoS One. 2013 Aug 15;8(8):e71343. doi: 10.1371/journal.pone.0071343. eCollection 2013.

19.

Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesions.

Berg SA, Sentir AM, Cooley BS, Engleman EA, Chambers RA.

Addict Biol. 2014 Nov;19(6):1020-31. doi: 10.1111/adb.12082. Epub 2013 Aug 6.

20.

High-affinity nicotinic acetylcholine receptor expression and trafficking abnormalities in psychiatric illness.

Lewis AS, Picciotto MR.

Psychopharmacology (Berl). 2013 Oct;229(3):477-85. doi: 10.1007/s00213-013-3126-5. Epub 2013 Apr 28. Review.

Supplemental Content

Support Center